Pacifica, CA, United States of America

Martin Neitzel

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Concord, CA (US) (2007 - 2009)
  • Pacifica, CA (US) (2007 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Martin Neitzel: A Trailblazer in Cognitive Disorder Research

Introduction

Martin Neitzel, based in Pacifica, California, is an accomplished inventor with a remarkable portfolio of 10 patents. His innovative work primarily focuses on developing treatments for cognitive disorders, particularly Alzheimer's Disease. Through his inventions, Neitzel aims to contribute significantly to the pharmaceutical industry and improve the lives of those affected by these conditions.

Latest Patents

Among Neitzel's most notable patents is his work on N-substituted benzene sulfonamides, an invention that provides these compounds for use in treating or preventing cognitive disorders, specifically Alzheimer's Disease. The compounds of particular interest are defined by Formula (I), where R, R, R, R, and R are as specified in the documentation. This invention not only includes the pharmaceutical compositions comprising the compounds of Formula (I) but also the methods for treating cognitive disorders using these compounds. This innovation is expected to pave the way for new therapeutic options.

Career Highlights

Neitzel has built a successful career in the pharmaceutical sector, showcasing his expertise and commitment to research and development. He has been instrumental in advancing treatment modalities for cognitive disorders, which has earned him recognition in the scientific community. His work at Elan Pharmaceuticals, Inc. has been pivotal in pushing the boundaries of what is possible in neuropharmacology.

Collaborations

Throughout his career, Martin Neitzel has collaborated with talented coworkers, including Jennifer Marugg and Albert W. Garofalo. These partnerships have allowed him to exchange ideas and enhance his research, which significantly contributes to the ongoing efforts in developing effective treatments for cognitive disorders.

Conclusion

Martin Neitzel is a significant figure in the field of pharmaceutical innovation, particularly in the area of cognitive disorder treatments. With his continued work and commitment to research, he is sure to impact the lives of many individuals affected by Alzheimer's Disease and other cognitive conditions. His patents in N-substituted benzene sulfonamides represent a promising advancement in this crucial area of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…